Viemed Healthcare (VMD) Liabilities and Shareholders Equity (2018 - 2026)

Viemed Healthcare (VMD) has 9 years of Liabilities and Shareholders Equity data on file, last reported at $197.4 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 10.83% year-over-year to $197.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $783.5 million (up 13.77% YoY) and the FY2025 annual result came in at $199.2 million, up 12.47% from the prior year.
• Liabilities and Shareholders Equity retreated to $197.4 million in Q1 2026, from $199.2 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $202.4 million in Q3 2025 to a low of $115.9 million in Q2 2022.
• A 5-year average of $157.4 million and a median of $154.9 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 0.78% — and 2023, when it jumped 32.34%.
• Tracing VMD's Liabilities and Shareholders Equity over 5 years: stood at $117.0 million in 2022, then surged by 32.34% to $154.9 million in 2023, then rose by 14.32% to $177.1 million in 2024, then advanced by 12.47% to $199.2 million in 2025, then fell by 0.9% to $197.4 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $197.4 million (Q1 2026), $199.2 million (Q4 2025), and $202.4 million (Q3 2025), per Business Quant data.